Literature DB >> 29126810

Sensory trick splint as a multimodal therapy for oromandibular dystonia.

Kazuya Yoshida1.   

Abstract

PURPOSE: Many patients with oromandibular dystonia, which is characterized by involuntary masticatory, lower facial, and/or tongue muscle contractions, experience relief of symptoms through sensory tricks such as eating chewing gum or candy. The aim of this study was to identify the factors influencing the effects of splints in patients with oromandibular dystonia.
METHODS: Occlusal splints were inserted in 128 patients (89 women, 39 men) with oromandibular dystonia (102 with jaw closing dystonia, 20 with lingual dystonia, 5 with jaw deviation dystonia, 4 with jaw opening dystonia, 3 with lip dystonia, and 2 with jaw protrusion dystonia). Patients who showed improvement with the use of splints and continued to wear them for at least 3 months were defined as responders. In contrast, patients who showed little or no effect and/or were unable to insert splints were defined as non-responders. Differences in demographic and clinical data were statistically compared between responders and non-responders.
RESULTS: Ninety-eight patients (76.6%) were responders (subjective improvement: 30.5%). Thirty patients (23.4%) were non-responders (subjective improvement: 7.2%). The responders were significantly older than the non-responders (53.8 years vs 47.0 years; p<0.05). Patients with jaw closing dystonia showed the most favorable results. The proportion of patients with sensory tricks was significantly higher in responders than in non-responders (66.3% vs 26.7%; p<0.05).
CONCLUSIONS: The sensory trick splint is especially helpful for patients with jaw closing dystonia. It is useful, although partially effective, as an alternative therapy in patients for whom other therapies have been unsatisfactory.
Copyright © 2017 Japan Prosthodontic Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dental device; Jaw closing dystonia; Occlusal splint; Oromandibular dystonia; Sensory tricks

Mesh:

Year:  2017        PMID: 29126810     DOI: 10.1016/j.jpor.2017.09.004

Source DB:  PubMed          Journal:  J Prosthodont Res        ISSN: 1883-1958            Impact factor:   4.642


  9 in total

1.  Prevalence and incidence of oromandibular dystonia: an oral and maxillofacial surgery service-based study.

Authors:  Kazuya Yoshida
Journal:  Clin Oral Investig       Date:  2021-05-06       Impact factor: 3.573

Review 2.  Movement disorders of the mouth: a review of the common phenomenologies.

Authors:  C M Ghadery; L V Kalia; B S Connolly
Journal:  J Neurol       Date:  2022-07-29       Impact factor: 6.682

3.  Clinical and Phenomenological Characteristics of Patients with Task-Specific Lingual Dystonia: Possible Association with Occupation.

Authors:  Kazuya Yoshida
Journal:  Front Neurol       Date:  2017-12-11       Impact factor: 4.003

4.  Multilingual website and cyberconsultations for oromandibular dystonia.

Authors:  Kazuya Yoshida
Journal:  Neurol Int       Date:  2018-03-30

5.  Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features.

Authors:  Kazuya Yoshida
Journal:  Toxins (Basel)       Date:  2019-01-17       Impact factor: 4.546

Review 6.  Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System.

Authors:  Kazuya Yoshida
Journal:  Toxins (Basel)       Date:  2022-04-14       Impact factor: 5.075

7.  Botulinum Neurotoxin Injection for the Treatment of Recurrent Temporomandibular Joint Dislocation with and without Neurogenic Muscular Hyperactivity.

Authors:  Kazuya Yoshida
Journal:  Toxins (Basel)       Date:  2018-04-25       Impact factor: 4.546

8.  Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.

Authors:  Kazuya Yoshida
Journal:  Toxins (Basel)       Date:  2021-08-29       Impact factor: 4.546

Review 9.  Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care.

Authors:  Brent Bluett; Alexander Y Pantelyat; Irene Litvan; Farwa Ali; Diana Apetauerova; Danny Bega; Lisa Bloom; James Bower; Adam L Boxer; Marian L Dale; Rohit Dhall; Antoine Duquette; Hubert H Fernandez; Jori E Fleisher; Murray Grossman; Michael Howell; Diana R Kerwin; Julie Leegwater-Kim; Christiane Lepage; Peter Alexander Ljubenkov; Martina Mancini; Nikolaus R McFarland; Paolo Moretti; Erica Myrick; Pritika Patel; Laura S Plummer; Federico Rodriguez-Porcel; Julio Rojas; Christos Sidiropoulos; Miriam Sklerov; Leonard L Sokol; Paul J Tuite; Lawren VandeVrede; Jennifer Wilhelm; Anne-Marie A Wills; Tao Xie; Lawrence I Golbe
Journal:  Front Neurol       Date:  2021-07-01       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.